期刊文献+

量子点荧光探针在人舌鳞状细胞癌组织中的应用研究 被引量:3

Application of quantum dots fluorescent probes in tissue of human tongue squamous cell carcinoma
下载PDF
导出
摘要 目的通过免疫荧光技术,利用量子点荧光探针在人的舌鳞状细胞癌组织中检测特定蛋白,探讨量子点荧光探针在人舌鳞状细胞癌组织中的应用。方法相同粒径的量子点通过间接免疫荧光技术分别对人舌鳞状细胞癌组织中的P53及Bcl-2蛋白进行特异荧光标记,荧光显微镜观察蛋白定位表达;不同粒径的量子点通过间接免疫荧光技术,在同一张舌鳞状细胞癌组织切片上分别标记P53蛋白与Bcl-2蛋白,并对其定位表达进行观察。结果相同粒径的量子点荧光探针可分别与组织中的P53、Bcl-2蛋白结合,在紫外荧光激发下发出特异红色荧光,P53蛋白结合物主要分布于细胞核;Bcl-2蛋白结合物主要分布于细胞质;不同粒径的量子点荧光探针在同一张组织切片上可同时对P53蛋白与Bcl-2蛋白进行标记,在紫外荧光激发下2种蛋白结合物发出2种不同颜色的荧光形成鲜明对比,显示量子点荧光探针标记的蛋白定位准确,特异性高。结论量子点荧光探针可应用于人舌鳞状细胞癌组织中的2种蛋白的特异免疫荧光标记。 Objective To study if quantum dots fluorescent probes can be applied to detect P53 protein and Bcl-2 protein in tissue of human tongue squamous cell carcinoma.Methods By indirect immunofluorescence assay the same particle size quantum dots fluorescent probes were applied to detect P53 protein and Bcl-2 protein respectively.Different particle size quantum dots fluorescent probes were applied to detect P53 protein and Bcl-2 protein simultaneously in paraffin-embedded tissue section of human tongue squamous cell carcinoma under fluorescent microscope.Results P53 protein and Bcl-2 protein can be combined with quantum dots fluorescent probes and specific fluorescene can be observed with ultraviolet light excited.P53 protein was mainly distributed in the nucleus,and Bcl-2 protein major in the cytoplasm.P53 protein and Bcl-2 protein can be combined with different particle size quantum dots fluorescent probes respectively in the same paraffin-embedded tissue section of human tongue squamous cell carci-noma and two kinds of fluorescene can be observed.Conclusion Quantum dots fluorescent probes can be applied to detect two kinds of specific protein in paraffin-embedded tissue section of human tongue squamous cell carcinoma.
出处 《华西口腔医学杂志》 CAS CSCD 北大核心 2011年第2期175-178,共4页 West China Journal of Stomatology
基金 国家自然科学基金资助项目(30672340) 广东省科技计划基金资助项目(2008B030301183)
关键词 量子点荧光探针 舌鳞状细胞癌 免疫荧光 quantum dots fluorescent probe tongue squamous cell carcinoma immunofluorescence
  • 相关文献

参考文献15

  • 1Hall M,Kazakova I,Yao YM.High sensitivity immunmssays using particulate fluorescent labela[J].Anal Biechem,1999,272(2):165-170.
  • 2盘杰,赵建江,王治平,黄宇华,陈军.量子点荧光技术标记口腔鳞癌细胞中bcl-2的研究[J].中山大学学报(医学科学版),2009,30(5):634-635. 被引量:6
  • 3Bruchez M Jr,Moronne M,Gin P,et al.Semiconductor nanocrystals as fluorescent biological labels[J].Science,1998,281(5385):1930-1931.
  • 4Pitsillides CM,Joe EK,Wei X,et al.Selective cells targeting with light-absorbing micropaticles and nanoparticles[J].Biophys J,2003,84(6):4023-4032.
  • 5Alivisatos P.The use of nanocrystals in biologlcal detection[J].Nat Biotechnol,2004,22(1):47-52.
  • 6方凤琴,黄金颖,刘文中,董慧蕾,李奕.头颈鳞癌p53、Bcl-2及P-gp表达在治疗中的作用[J].实用肿瘤学杂志,2007,21(6):516-518. 被引量:3
  • 7Huang HY,Illei PB,Zhao Z,et al.Ewing sarcomas with p53mutation or p16/p14ARF homozygous deletion:A highly lethal subset associated with poor chemoresponse[J].J Clin Oncol,2005,23(3):548-558.
  • 8yamazaki Y,Chiba I,Hirai A,et al.Radioresistance in oral squamous cell carcinoma with p53 DNA contact mutatlon[J].Am J Clin Oncol,2003,26(5):e124-e129.
  • 9陈洪雷,朱小波,张玉霞,夏东,李蓓芸.量子点免疫标记技术在肺癌组织芯片上的应用[J].武汉大学学报(医学版),2008,29(5):607-609. 被引量:7
  • 10Gbezani AA,Lee JA,Klostranec J,et al.High throughput quantification of protein expression of cancer antigens in tissue microarray using quantum dot nanocrystals[J].Nano Lett,2006,6(12):2881-2886.

二级参考文献22

  • 1Hui-ZhiWANG Hai-YanWANG Ru-QiangLIANG Kang-ChengRUAN.Detection of Tumor Marker CA125 in Ovarian Carcinoma Using Quantum Dots[J].Acta Biochimica et Biophysica Sinica,2004,36(10):681-686. 被引量:15
  • 2Sukhanova A,Devy J,Venteo.L,et al.Biocompatible fluorescent nanocrystels for immunolabelingof membrane proteins and cells[J].Anal Biochem,2004,324(1):60-67.
  • 3Garon EB,Marcu L,Luong Q,et al.Quantum dot labeling and tracking of human leukemic,bone marrow and cord blood cell[J].Leuk Res,2007,31(5):643-651.
  • 4Hanaki K,Mono A,Oku T,et al.Semiconductor quantum dot/albumin complex is a long life and highly photostabable endooome marker[J].Biochem Biophys Res Commun,2003,302(3):496-501.
  • 5Staibano S,Mignogna MD,Lo Muzio L,et al.Overexpression of cyclin-D1,bcl-2,and bax proteins,proliferating cell nuclear antigen (PCNA),and DNA-ploidy in squamous cell carcinoma of the oral cavity[J].Hum Pathol,1998,29(11):1189-1194.
  • 6Li Z,Wang K,Tan W,et al.Immunofluorescent labeling of cancer cells with quantum dots synthesized in aqueous solution[J].Anal Biochem,2006,354(2):169-174.
  • 7长谷川正俊.化学放射线疗法の分子生物学.血液·肿瘤科,2000,40:72-78.
  • 8漆崎一朗.アボト-シスの诱导[J].综合临床,2001,50:155-159
  • 9田中信之.p53にょる细胞死分子机构[J].实验医学,2002,18:1793-1797
  • 10Chada S, Mhashilkar A, Roth JA. et al. Development of vaccines against self-antigens: the p53 paradigm[J]. Curr Opin Drug Discov Devel, 2003:6:169-173

共引文献13

同被引文献36

  • 1龚志军,罗恩钊,陆琪,施达仁,朱慰祺.胃癌组织c-erbB_2蛋白表达的临床意义[J].中华肿瘤杂志,1996,18(4):299-301. 被引量:26
  • 2Egcblad M, Werb Z. New functions for the matrix metalloproteinases in cancer progression [J]. Nat Rev Cancer, 2002,2 (3) : 16 1- 174.
  • 3Kusukawa J, Sasaguri Y, Shima I, et al. Expression of matrix metallo- proteinase-2 related to lymph node metastasis of oral squamuus cell carcinoma. A clinicopathologie study [J]. Am J Clin Pathol, 1993,99 (1) : 18-23.
  • 4Zhou Q, Gil-Krzewska A, Peruzzi G, et al. Matrix metalloproteinases inhibition promotes the polyfunctionality of human natural killer cells in therapeutic antibody-based anti-turnout immunotherapy [J]. Clin Exp Immunol, 2013, 173 (1) : 131-139.
  • 5Wang W,Sehulze CJ,Suarez-Pinzon WL, et al. Intracellular action of matrix metalloproteinase-2 accounts for acute myocardial ischernia and reperfusion injury[J]. Circulation, 2002, 106 (12): 1543-1549.
  • 6Sawieki G,Leon H,Sawicka J,et al. Degradation of myosin light chain in isolated rat hearts subjected to ischemia-reperfusion injury: a new intracellular target for matrix metalloproteinase-2 Eli.Circula- tion, 2005, 112 (4) : 544-552.
  • 7Kwan JA,Schulze CJ,Wang W,et al. Matrix metalloproteinase-2(MMP-2) is present in the nucleus of cardiac myocytes and is capa- ble of cleaving poly (ADP-ribose) polymerase (PARP) in vitro [J]. FASEB Journal, 2004, 18 (6) : 690-692.
  • 8Kessenbrock K, Plaks V,Werb Z. Matrix metalloproteinases." regula- tors of the tumor microenvironment [J]. Cell, 2010, 141 (1) : 52-67.
  • 9Klein T, Bischoff R. Physiology and pathophysiology of matrix metal- loproteases [J]. Amino Acids, 2011,41 (2) : 271-290.
  • 10Cauwe B, Van den Steen PE, Opdenakker G. The biochemical, bio-logical, and pathological kaleidoscope of cell surface substrates pro- cessed by matrix metalloproteinases [J]. Crit Rev Biochem Mol Bi- ol, 2007,42 (3) : 113-185.

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部